| Literature DB >> 32824913 |
Carla Bezold1, Samantha J Bauer1, Jessie P Buckley2, Stuart Batterman3, Haifa Haroon1, Lauren Fink1.
Abstract
Older buildings in the United States often contain lead paint, and their demolition poses the risk of community lead exposure. We investigated associations between demolitions and elevated blood lead levels (EBLLs) among Detroit children aged <6 years, 2014-2018, and evaluated yearly variation given health and safety controls implemented during this time. Case-control analysis included incident EBLL cases (≥5 µg/dL) and non-EBLL controls from test results reported to the Michigan Department of Health and Human Services. Exposure was defined as the number of demolitions (0, 1, 2+) within 400 feet of the child's residence 45 days before the blood test. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs), and test effect modification by year. Associations between demolition and EBLL differed yearly (p = 0.07): 2+ demolitions were associated with increased odds of EBLLs in 2014 (OR: 1.75; 95% CI: (1.17, 2.55), 2016 (2.36; 1.53, 3.55) and 2017 (2.16; 1.24, 3.60), but not in 2018 (0.94; 0.41, 1.86). This pattern remained consistent in sensitivity analyses. The null association in 2018 may be related to increased health and safety controls. Maintenance of controls and monitoring are essential, along with other interventions to minimize lead exposure, especially for susceptible populations.Entities:
Keywords: children; demolitions; elevated blood lead level; lead; negative control
Mesh:
Substances:
Year: 2020 PMID: 32824913 PMCID: PMC7503460 DOI: 10.3390/ijerph17176018
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Prevalence of elevated blood lead levels in Detroit, 2014–2018.
| 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|
| Number of children <6 years old with a reported blood lead test (one observation per child per year) | 19,820 | 22,216 | 23,408 | 21,404 | 23,134 |
| EBLL (≥5 µg/dL) | 1406 | 1658 | 2055 | 1624 | 1915 |
| Percent EBLL (%) | 7.1 | 7.5 | 8.8 | 7.6 | 8.3 |
Note: Elevated blood lead level (EBLL). Data from the Michigan Department of Health and Human Services Data Warehouse. The table includes one observation per child per year. Children can be included in multiple years. If a child had multiple tests in a year, only the highest result from a venous sample was retained. If no result from a venous sample was available, the highest result from a capillary or unknown sample was used.
Figure 1Incident cases of elevated blood lead levels among children under 6, Detroit, 2014–2018. Note: Heat map based on kernel density method, which calculates the density of point features around each output raster cell, with a feature count radius of 10. Elevated blood lead level incidence includes both venous and capillary lead tests. Data from the Michigan Department of Health and Human Services Data Warehouse.
Figure 2Percentage of children tested identified to have elevated blood lead levels by ZIP code, Detroit, 2016. Note: Data from the Michigan Department of Health and Human Services Division of Environmental Health (version 6/16/2018), 2016 Data Report on Childhood Lead Testing and Elevated Levels: Michigan. Percentage of children with elevated blood lead levels includes both venous and capillary tests. Zip Codes outlined in white indicate the 5 areas where the demolition moratorium was implemented in 2018.
Figure 3Number of demolitions by census tract in Detroit, 2014–2018. Note: Demolition data from City of Detroit Open Data Portal. Numbers represent the total number of demolitions between January 2014 and December 2018.
Demolition exposure by children’s blood lead level, Detroit, 2014–2018 (N = 109,982 observations).
| Number of Demolitions within 400 Feet of Residence in 45 Days Prior to Blood Lead Test | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | Total | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ≥10 | |
| 2014 | BLL < 5 µg/dL | 21,219 | 20,075 | 787 | 193 | 73 | 32 | 26 | 11 | 5 | 5 | 5 | 7 |
| BLL ≥5 µg/dL | 1915 | 1768 | 90 | 27 | 14 | 8 | * | * | 0 | * | 0 | * | |
| 2015 | BLL < 5 µg/dL | 19,780 | 18,561 | 867 | 200 | 80 | 36 | 22 | * | 7 | * | 0 | * |
| BLL ≥ 5 µg/dL | 1624 | 1505 | 93 | 14 | * | 9 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2016 | BLL < 5 µg/dL | 21,353 | 20,217 | 906 | 168 | 32 | 17 | * | * | * | * | * | * |
| BLL ≥ 5 µg/dL | 2055 | 1901 | 106 | 29 | 7 | 5 | * | * | 0 | 0 | 0 | * | |
| 2017 | BLL < 5 µg/dL | 20,558 | 19,851 | 580 | 78 | 21 | 14 | * | 6 | * | * | 0 | * |
| BLL ≥ 5 µg/dL | 1658 | 1558 | 72 | 13 | 8 | * | 0 | * | 0 | 0 | 0 | * | |
| 2018 | BLL < 5 µg/dL | 18,414 | 17,516 | 717 | 116 | 40 | 18 | * | * | 0 | 0 | 0 | * |
| BLL ≥ 5 µg/dL | 1406 | 1342 | 48 | 13 | * | 0 | 0 | * | 0 | 0 | 0 | 0 | |
| 2014–2018 | BLL < 5 µg/dL | 101,324 | 96,220 | 3857 | 755 | 246 | 117 | 59 | 24 | 16 | 9 | 8 | 13 |
| BLL ≥ 5 µg/dL | 8658 | 8074 | 409 | 96 | 34 | 24 | * | 10 | 0 | * | 0 | 6 | |
Note: Blood lead level (BLL). Data from the Michigan Department of Health and Human Services Data Warehouse. The table includes one observation per child per year. Children can be included in multiple years. If a child had multiple tests in a year, only the highest result from a venous sample was retained. If no result from a venous sample was available, the highest result from a capillary or unknown sample was used. * indicates data suppressed due to a cell count <5.
Descriptive characteristics of cases (incident elevated blood lead levels among children <6 years old) and controls (N = 54,150 observations, 5430 cases), Detroit, 2014–2018.
| Cases | Controls | ||
|---|---|---|---|
| Age | <1 year | 279(5) | 7613(16) |
| 1–2 years | 3335(61) | 26,862(55) | |
| 3–5 years | 1816(33) | 14,245(29) | |
| Gender | F | 2416(44) | 23,967(49) |
| M | 2956(54) | 24,276(50) | |
| Unknown | 58(1) | 477(1) | |
| Month | January | 307(6) | 3836(8) |
| February | 250(5) | 3579(7) | |
| March | 296(5) | 4239(9) | |
| April | 323(6) | 3977(8) | |
| May | 398(7) | 4108(8) | |
| June | 568(10) | 3875(8) | |
| July | 578(11) | 3826(8) | |
| August | 730(13) | 4973(10) | |
| September | 813(15) | 5464(11) | |
| October | 537(10) | 4381(9) | |
| November | 370(7) | 3495(7) | |
| December | 260(5) | 2967(6) | |
| Year | 2014 | 1206(22) | 9972(20) |
| 2015 | 995(18) | 8835(18) | |
| 2016 | 1269(23) | 10,169(21) | |
| 2017 | 1013(19) | 10,101(21) | |
| 2018 | 947(17) | 9643(20) | |
| Specimen Type | Capillary | 1129(21) | 10,389(21) |
| Venous | 4300(79) | 38,011(78) | |
| Unknown | 1(0) | 320(1) | |
| Demolitions within 400 feet, 45 days before test | 0 | 5054(93) | 46,419(95) |
| 1 | 255(5) | 1755(4) | |
| 2 | 121(2) | 546(1) |
Note: Cases were defined as the first venous test with a result ≥5 µg/dL; for individuals who did not have any venous tests during 2012–2018, the first test from a capillary or unknown specimen type with a result ≥5 µg/dL was considered an incident EBLL. The date the specimen was collected was used as the incident test date. Controls were individuals without an EBLL during the study period; the incident test date was the first result from a venous test where available and from a capillary test where no venous test was available.
Results of a case-control analysis of the association between demolitions and incident elevated blood lead levels among children <6 years old, by calendar year, Detroit, 2014–2018 (N = 54,150 observations, 5430 cases).
| 2018 | 2017 | 2016 | 2015 | 2014 | Overall | |
|---|---|---|---|---|---|---|
| Incident EBLL cases | 947 | 1013 | 1269 | 995 | 1206 | 5430 |
| 0 Demolitions before test | 900 | 950 | 1171 | 918 | 1115 | 5054 |
| 1 Demolition before test | 39 | 43 | 63 | 59 | 51 | 255 |
| 2 Demolitions before test | 8 | 20 | 35 | 18 | 40 | 121 |
| Controls | 9643 | 10,101 | 10,169 | 8835 | 9972 | 48,720 |
| 0 Demolitions before test | 9197 | 9762 | 9662 | 8312 | 9486 | 46,419 |
| 1 Demolition before test | 356 | 270 | 414 | 373 | 342 | 1755 |
| 2 Demolitions before test | 90 | 69 | 93 | 150 | 144 | 546 |
| Main analysis | OR 95% CI | OR 95% CI | OR 95% CI | OR 95% CI | OR 95% CI | OR 95% CI |
| 1 Demolition before test (main exposure) | 0.96 | 1.51 | 1.24 | 1.32 | 1.03 | 1.19 |
| (0.67, 1.33) | (1.06, 2.10) | (0.92, 1.63) | (0.98, 1.76) | (0.74, 1.39) | (1.03, 1.36) | |
| 2 or More Demolitions before test (main exposure) | 0.94 | 2.16 | 2.36 | 1.03 | 1.75 | 1.63 |
| (0.41, 1.86) | (1.24, 3.60) | (1.53, 3.55) | (0.60, 1.68) | (1.17, 2.55) | (1.32, 2.00) | |
| 1 Demolition after test (negative control exposure) | 0.96 | 1.36 | 1.17 | 1.01 | 1.28 | 1.14 |
| (0.67, 1.34) | (0.96, 1.87) | (0.84, 1.61) | (0.72, 1.37) | (0.96, 1.69) | (0.99, 1.31) | |
| 2 or More Demolitions after test (negative control exposure) | 1.00 | 1.46 | 0.86 | 0.89 | 1.39 | 1.11 |
| (0.53, 1.73) | (0.81, 2.49) | (0.46, 1.49) | (0.47, 1.55) | (0.89, 2.11) | (0.88, 1.40) | |
| Demolitions before test only | OR 95% CI | OR 95% CI | OR 95% CI | OR 95% CI | OR 95% CI | OR 95% CI |
| 1 Demolition | 0.95 | 1.52 | 1.24 | 1.32 | 1.05 | 1.19 |
| (0.67, 1.33) | (1.07, 2.11) | (0.92, 1.63) | (0.98, 1.76) | (0.76, 1.42) | (1.04, 1.37) | |
| 2 or More Demolitions | 0.94 | 2.30 | 2.35 | 1.03 | 1.89 | 1.66 |
| (0.41, 1.86) | (1.33, 3.82) | (1.53, 3.55) | (0.60, 1.67) | (1.28, 2.73) | (1.35, 2.04) |
Note: Cases were defined as the first venous test with a result ≥5 µg/dL; for individuals who did not have any venous tests during 2012–2018, the first test from a capillary or unknown specimen type with a result ≥5 µg/dL was considered an incident EBLL. The date the specimen was collected was used as the incident test date. Controls were individuals without an EBLL during the study period; the incident test date was the first result from a venous where available and from a capillary test where no venous was available. Results were estimated in logistic regression models adjusted for specimen type (venous, capillary, unknown), month and year of collection, age category (<1, 1–2, 3–5 years), gender, and ZIP code.